Overview

Naloxegol and Opioid-induced Constipation

Status:
Recruiting

Trial end date:
2020-12-01

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomized, placebo-controlled trial to examine the effectiveness of adding one 25mg dose of naloxegol to the cardiac surgery pre-operative regimen.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Angela Fellner
TriHealth Inc.

Collaborator:

Emily Craver

Treatments:

Analgesics, Opioid
Naloxegol